Clinical Trials Logo

Clinical Trial Summary

This pilot study will test the feasibility and tolerability of the tethered OCT capsule and Trans Nasal Endomicroscopy probe and accessory devices for imaging the small intestine in subjects with EED and a matched non-EED cohort. This study will assess subject tolerability, optimal imaging technique, and imaging of EED features.


Clinical Trial Description

Environmental enteric dysfunction (EED) is a poorly understood condition characterized by intestinal inflammation and loss of barrier function that is prevalent in regions of the world with inadequate sanitation and hygiene. EED is a major driver of malnourishment, poor neurological development, stunting, oral vaccine failure, and infection, affecting 25% of all children globally and causing over a million deaths each year . It is hypothesized that the stunting associated with EED begins in utero and that the mother's gut health has a significant impact on the fetus. Key periods of growth from pregnancy through birth and childhood offer windows for potential intervention Progress towards understanding EED and developing effective interventions has been hampered by an inability to evaluate the intestinal mucosa of populations in impoverished regions of the world where this condition is endemic. The Tearney Laboratory has developed a minimally invasive screening method known as tethered capsule endomicroscopy (TCE) for imaging intestinal mucosa. With TCE, an unsedated subject swallows a tethered pill, which captures microscopic images of the entire esophagus, stomach, and small intestine, as it is naturally transits these organs via peristalsis and under the influence of gravity. The capsule implements a microscopic imaging technology called optical coherence tomography (OCT) that obtains 10-µm-resolution cross-sectional images of tissue. The procedure is brief, well tolerated, and can be much less expensive than endoscopy. The Investigators have implemented TCE for imaging the upper gastrointestinal tract of adults and adolescents with Celiac Disease (CD) and eosinophilic esophagitis (EoE), inflammatory conditions that are common in the US. The qualities seen thus far in their TCE studies - high imaging resolution, comprehensive tissue assessment, and minimal invasiveness - are also the qualities needed for evaluating the intestinal mucosa in populations with EED. The Tearney Lab has also developed a new technique of deployment, Trans Nasal Endomicroscopy (TNE). The TNE catheter comprises of an introduction tube, similar to a standard Nasojejunal tube, with one or two balloons attached at the distal end. These balloons are inflated with Galinstan , a safe liquid metal alloy used in pediatric thermometers, or saline or sugar water or air which provides weight for the device to move to the duodenum under the forces of gravity and peristalsis. The TNE catheter encloses the OCT optics within, and is designed to have many of the same imaging properties of TCE but is introduced Trans nasally so that it can be effectively used in children, infants and also enable collection of various tissue samples using accessory probes for analysis through the lumen of the introduction tube. There have been theories proposed that increased microorganism load and/or dysbiosis or an imbalance in the composition of gut microorganisms in the intestine may be important in the establishment and/or maintenance of EED. Duodenal Aspiration during endoscopy is currently used as gold standard for standard of care to collect targeted microbiome. However, the microbiome yield from this procedure is low and the procedure requires an EGD, which is a fairly invasive procedure, and carries all of the risks associated with an EGD . Tearney lab has developed a brush that can collect microbiota samples from the small intestine, in the unsedated subject in a non-invasive manner. The brush is similar to cytology brush used in standard clinical care, designed to be deployed through the TNIT tube. The first phase of this study will test the feasibility and tolerability of the TCE device for imaging subjects with EED. The second phase of this study will test the TNE device and its accessories for imaging and microbial sample collection in pregnant women. ;


Study Design


Related Conditions & MeSH terms

  • Environmental Enteric Dysfunction

NCT number NCT04275167
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date October 11, 2017
Completion date January 2029

See also
  Status Clinical Trial Phase
Recruiting NCT04984447 - OCT Guided Trans Nasal Imaging of the Small Intestine in Adults N/A
Recruiting NCT06002438 - Eggs for Gut Health N/A
Completed NCT02925026 - Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction N/A
Completed NCT03263871 - PTM202 for the Treatment of Environmental Enteric Dysfunction (EED) N/A
Recruiting NCT03313128 - SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Completed NCT02760095 - Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Completed NCT02758444 - Effects of EED on Zn Absorption and Retention in Children From a MNP N/A
Recruiting NCT06196450 - Maternal Probiotic Intervention to Improve Gut Health Phase 2
Completed NCT05291559 - Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh N/A
Terminated NCT03782272 - Safety, Acceptability, and Feasibility of Enterade® N/A
Completed NCT03801317 - The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children N/A
Not yet recruiting NCT05501470 - Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal Phase 2
Recruiting NCT05922683 - Maternal Probiotic Intervention to Improve Gut Health Phase 2